This article is part of the supplement: Breast Cancer Research 2008
Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes
Breast Cancer Research 2008, 10(Suppl 2):O6 doi:10.1186/bcr1881
Accesses
- Last 30 days: 32 accesses
- Last 365 days: 263 accesses
- All time: 1362 accesses